perhexiline maleate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
Perhexiline maleate, which causes inhibition of myocardial fatty acid catabolism with a concomitant increase in glucose… (More)
Is this relevant?
1986
1986
The clinical utility of adriamycin in the treatment of patients with metastatic breast cancer is oftenlimited by the development… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 6
  • figure 7
Is this relevant?
1984
1984
Long term perhexiline maleate therapy causes peripheral neuropathy and hepatic damage in certain subjects. An association between… (More)
  • table I
  • table 2
  • figure I
  • figure 2
Is this relevant?
1984
1984
The effects of perhexiline maleate on growth and drug sensitivity were studied in the P388 murine leukemia cell line and in an… (More)
Is this relevant?
1983
1983
Perhexiline maleate is a potent anti-anginal drug which may cause alcoholic-type hepatitis and cirrhosis. We report a case of a… (More)
Is this relevant?
1982
1982
The use of perhexiline maleate as an antianginal agent is occasionally associated with side effects, particularly neuropathy and… (More)
  • table I
Is this relevant?
1979
1979
Peripheral neuropathy has been noted as a complication of therapy with perhexiline maleate, a drug widely used in France (and in… (More)
Is this relevant?
1979
1979
Two patients who developed biochemical and histological evidence of hepatitis while taking the anti-anginal drug perhexiline… (More)
Is this relevant?
1978
1978
Perhexiline maleate (Pexid ®) which has been in general use in France with good results for the treatment of angina pectoris… (More)
  • figure 1
  • figure 3
  • table 1
  • table 2
  • table 3
Is this relevant?
1971
1971
This paper reports a double-blind trial of a new antianginal drug, perhexiline. Fifty-five patients suffering from angina… (More)
Is this relevant?